시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 재택 화학요법 서비스 시장 보고서(2025년)
Chemotherapy At Home Services Global Market Report 2025
상품코드 : 1703113
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,265,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,056,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,846,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

재택 화학요법 서비스 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 11.1%의 성장률로 29억 7,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장 배경에는 의료 비용 상승, 고령화, 재택치료 서비스 확대, 환자 중심 치료에 대한 관심 증가, 입원 일수 감소에 대한 요구 증가, 만성 질환 관리 등이 있습니다. 예측 기간의 주요 동향으로는 AI와 머신러닝의 통합, 개인 맞춤형 의료 접근법, 웨어러블 헬스 기술, 전문 재택 수액 서비스의 성장, 공동 의료 모델 등이 있습니다.

암 발병률 증가는 향후 재택 화학요법 서비스 시장의 성장을 견인할 것으로 예측됩니다. 암은 체내 비정상 세포의 통제할 수 없는 증식과 확산으로 특징지어지는 질병입니다. 고령화, 생활습관 변화, 환경 노출, 유전적 소인, 더 나은 발견으로 이어지는 고급 진단 기술 등 여러 요인이 암 유병률 증가에 기여하고 있습니다. 재택 화학요법 서비스는 암환자가 집에서 편안하게 치료를 받을 수 있도록 하여 편의성을 높이고 삶의 질을 향상시킬 수 있습니다. 예를 들어, 미국 정부 간 기관인 국립생명공학정보센터(National Center for Biotechnology Information)는 2023년 1월 미국에서 195만 8,310명의 암환자가 새로 발생하고 60만 9,820명이 사망할 것으로 예측했습니다. 이에 따라 암 유병률 증가가 재택 화학요법 서비스 수요를 견인하고 있습니다.

화학 요법 재택 서비스 시장의 기업들은 화학 요법 제공에 혁명을 일으키고 환자의 안전과 편의성을 향상시키는 혁신적인 솔루션을 제공합니다. 화학 요법 케어 서비스는 환자의 집에서 화학 요법을 실시하여 편안함과 편리함을 높입니다. 예를 들어, 2022년 9월 인도에 본사를 둔 모바일 의료 서비스 제공업체인 지비카 헬스케어는 암 환자를 위한 화학요법 치료 서비스인 ChemoAtHome을 발표했습니다. ChemoAtHome은 환자의 자택에 병원과 같은 시설을 설치하고 MBBS 의사의 감독 하에 훈련된 간호사가 안전하고 질 높은 암 치료를 제공하는 서비스로, 편리함과 비용 절감을 목표로 하고 있으며, 화학요법에 소요되는 병원비를 20-25% 절감할 수 있는 잠재력이 있습니다. 할 수 있습니다. 이 서비스에는 종양 전문의와의 가상 상담, 택배 약품 등 화학요법 전후의 지원도 포함됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Chemotherapy at-home services are an outpatient care option provided by a team of doctors and nurses, allowing cancer patients to receive their treatments at home. These services offer cancer patients the convenience of receiving chemotherapy treatments in the comfort of their own homes instead of in traditional clinical settings such as hospitals or specialized treatment centers.

The products included in chemotherapy at-home services are chemotherapy drugs and chemotherapy infusion pumps. Chemotherapy drugs are medications used to treat cancer by targeting and destroying cancer cells and can be administered orally or intravenously. These services are provided for applications such as breast cancer, blood cancer, ovarian cancer, and colorectal cancer.

The chemotherapy at home services market research report is one of a series of new reports from The Business Research Company that provides chemotherapy at home services market statistics, including the chemotherapy at home services industry global market size, regional shares, competitors with chemotherapy at home services market share, detailed chemotherapy at home services market segments, market trends, and opportunities, and any further data you may need to thrive in the chemotherapy at home services industry. These chemotherapy at home services market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chemotherapy at home services market size has grown rapidly in recent years. It will grow from $1.75 billion in 2024 to $1.95 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to increased cancer incidence, growing patient demand for receiving care at home, hospital capacity constraints, improved home healthcare infrastructure, and supportive government policies.

The chemotherapy at home services market size is expected to see rapid growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to rising healthcare costs, aging population, expansion of home healthcare services, increased focus on patient-centric care, increased need to reduce inpatient stays and chronic disease management. Major trends in the forecast period include integration of AI and machine learning, personalized medicine approaches, wearable health technology, growth of specialty home infusion services, and collaborative healthcare models.

The rising incidence of cancer is expected to drive the growth of the chemotherapy-at-home services market in the future. Cancer is a disease marked by the uncontrolled growth and spread of abnormal cells in the body. Several factors contribute to the growing prevalence of cancer, including aging populations, lifestyle changes, environmental exposures, genetic predispositions, and more advanced diagnostic techniques leading to better detection. Chemotherapy-at-home services enable cancer patients to receive treatment in the comfort of their homes, offering greater convenience and improving their quality of life. For example, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported 1,958,310 new cancer cases in the United States, with 609,820 projected cancer deaths in 2023. As a result, the increasing prevalence of cancer is driving the demand for chemotherapy-at-home services.

Companies in the chemotherapy-at-home services market are offering innovative solutions to revolutionize chemotherapy delivery and improve patient safety and convenience. Chemotherapy care services involve delivering chemotherapy treatment in patients' homes for added comfort and ease. For instance, in September 2022, Jivika Healthcare, an India-based mobile medical service provider, introduced ChemoAtHome, a chemotherapy care service for cancer patients. This service provides safe and high-quality cancer care administered by trained nurses under an MBBS doctor's supervision, with hospital-like setups established at patients' residences. ChemoAtHome aims to offer convenience and cost savings, with potential savings of 20% to 25% on chemotherapy hospital bills. The service includes pre and post-chemotherapy support, such as virtual consultations with oncologists and home-delivered medications.

In August 2022, Walgreens, a US-based drugstore corporation, acquired a majority stake in CareCentrix for an undisclosed sum. This strategic move enables Walgreens to expand its healthcare services and deliver coordinated care to patients in their homes. CareCentrix, a US-based company, provides value-based home solutions to payors and health systems, including home-based chemotherapy infusions that benefit all stakeholders involved.

Major companies operating in the chemotherapy at home services market are CVS Health Corporation, Optum Inc, Fresenius Kabi, Medtronic plc, Amgen, Penn Medicine, Advocate Health Care, Medibank Private Limited, Option Care Health Inc., Amedisys Inc., Lincare Holdings Inc., Cancer Treatment Centers of America (CTCA), BioScrip Inc., Shanghai MicroPort Lifesciences Co. Ltd., Accredo Health Group Inc., LloydsPharmacy Clinical Homecare, InfuSystem Holdings Inc., Portea Medical, Amerita Inc., Jivika Healthcare, Vitalis Health and Home Care Pty Ltd, Ubiqare Health Pvt. Ltd., View Health Pty Ltd group, Sciensus Pharma Services Limited, TCP Homecare

North America was the largest region in the chemotherapy at-home services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy at home services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chemotherapy at home services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chemotherapy-at-home services market consists of revenues earned by entities by providing services such as telehealth support, and drug delivery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The chemotherapy-at-home services market also includes sales of portable infusion pumps, chemotherapy drug kits, and home care medical supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chemotherapy At Home Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chemotherapy at home services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for chemotherapy at home services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chemotherapy at home services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Chemotherapy At Home Services Market Characteristics

3. Chemotherapy At Home Services Market Trends And Strategies

4. Chemotherapy At Home Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chemotherapy At Home Services Growth Analysis And Strategic Analysis Framework

6. Chemotherapy At Home Services Market Segmentation

7. Chemotherapy At Home Services Market Regional And Country Analysis

8. Asia-Pacific Chemotherapy At Home Services Market

9. China Chemotherapy At Home Services Market

10. India Chemotherapy At Home Services Market

11. Japan Chemotherapy At Home Services Market

12. Australia Chemotherapy At Home Services Market

13. Indonesia Chemotherapy At Home Services Market

14. South Korea Chemotherapy At Home Services Market

15. Western Europe Chemotherapy At Home Services Market

16. UK Chemotherapy At Home Services Market

17. Germany Chemotherapy At Home Services Market

18. France Chemotherapy At Home Services Market

19. Italy Chemotherapy At Home Services Market

20. Spain Chemotherapy At Home Services Market

21. Eastern Europe Chemotherapy At Home Services Market

22. Russia Chemotherapy At Home Services Market

23. North America Chemotherapy At Home Services Market

24. USA Chemotherapy At Home Services Market

25. Canada Chemotherapy At Home Services Market

26. South America Chemotherapy At Home Services Market

27. Brazil Chemotherapy At Home Services Market

28. Middle East Chemotherapy At Home Services Market

29. Africa Chemotherapy At Home Services Market

30. Chemotherapy At Home Services Market Competitive Landscape And Company Profiles

31. Chemotherapy At Home Services Market Other Major And Innovative Companies

32. Global Chemotherapy At Home Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chemotherapy At Home Services Market

34. Recent Developments In The Chemotherapy At Home Services Market

35. Chemotherapy At Home Services Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기